0 references
Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
Critical Care2014Vol. 18(S1)
SL Cutuli, Gennaro De Pascale, Valeria Alicino, Silvia Cicconi, Valentina Di Gravio, Daniela Silvestri, D Giacobelli, E Gasperin, Silvia Marsili, MS Vallecoccia, Massimo Antonelli
Abstract
Endotoxin plays a crucial role in the pathogenesis of severe sepsis and septic shock (SS&SSh) [1]. The aim of this study is to analyze the impact of extracorporeal endotoxin removal with polymyxin B hemoperfusion (PMX-DHP) (Toraymyxin®).
Related Papers
- → Microbiological and chemical analysis of polymyxin B and polymyxin E (colistin) sulphates(1980)48 cited
- → Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium(1979)77 cited
- → Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis(2011)1 cited
- → Isolation and partial characterization of polymyxin B-resistant isolates of Vibrio parahaemolyticus(1996)
- → Polymyxins(1967)